Athersys to Produce Stem-Cell Treatment with Pfizer
December 21, 2009 at 17:35 PM EST
Bio-pharmaceutical company Athersys, Inc. has struck a deal with Pfizer to develop and market stem-cell treatments for irritable bowel disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.